Its marketed products include EYLEA, Dupixent, Libtayo, Kevzara, and others. On March 14, Evan Seigerman, an analyst from BMO Capital, maintained a Buy rating on the stock with a price target of $903.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands eighth among the most promising stocks according to Wall Street analysts. The company is focused on developing life-changing medicines for ...

Loblaw is making it easy for customers to identify which grocery products are caught in the crosshairs of Canada’s trade war with the U.S. A new “T” symbol—standing for “tariffs”—will be slapped on ...

IAB Tech Lab, the global digital advertising technical standards-setting body, has launched Trusted Server. This new open-source server-side ad management framework “gives publishers complete control ...

From foodservice and retail to packaging and equipment, discover the latest seafood products available to support your business or offer to your end customer with the SeafoodSource Product Showcase.